GreenLight’s mRNA vaccine nabs trial OK; Ratio reels in radiotherapy funds

GreenLight Biosciences will test its Covid-19 mRNA vaccine in Rwanda, the biotech said.

The RNA R&D and manufacturing company said the Rwanda FDA gave the go-ahead for a Phase I/II study testing the vaccine as a booster for people who have already been vaccinated against the pandemic virus.

“It is...

Click to view original post